Risk estimation for familial breast cancer: Improving the system of counselling

European Journal of Human Genetics

Volumn 15, Issue 11, 2007, Pages 1139-1144

  Gregory, Helen ^a   Wordsworth, Sarah ^b   Gibbons, Barbara ^a   Wilson, Brenda ^a   Haites, Neva ^c  

^a NHS GRAMPIAN   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Breast cancer; Cost; Model of care

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; FAMILIAL CANCER; FAMILY HISTORY; GENETIC COUNSELING; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; PATIENT REFERRAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENETIC COUNSELING; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 35548963392     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201895     Document Type: Article

References (16)

1. Tyczynski JE, Bray F, Maxwell Parkin D: Breast Cancer in Europe. ENCR Cancer Fact Sheets, vol. 2, 2002.
2. Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994; 73: 643-651.
3. Antoniou A, Pharoah PDP, Narod S et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117 -1130.
4. Thompson D, Easton DF, The Breast Cancer Linkage Consortium: Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94: 1358-1365.
5. Ford D, Easton DF, Stratton M et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998; 62: 676-689.
6. Fry A, Cull A, Appleton S et al: A randomised controlled trial of breast cancer genetics services in South East Scotland: Psychological impact. Br J Cancer 2003; 89: 653-659.
7. Torrance N, Mollison J, Wordsworth S et al: Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counseling. Evidence from two parallel randomised controlled equivalence trials. Br J Cancer 2006; 95: 435-444.
8. Douglas FS, O'Dair LC, Robinson M, Evans DG, Lynch SA: The accuracy of diagnoses as reported in families with cancer: A retrospective study. J Med Genet 1999; 36: 309-312.
9. Hopwood P, Wonderling D, Watson M et al: A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes. Br J Cancer 2004; 91: 884-892.
10. Henriksson K, Olson H, Kristoferson U: The need for oncogenetic counseling. Ten years' experience of a regional oncogenetic clinic. Acta Oncol 2004; 43: 637-649.
11. Steel M, Smyth E, Vasen H et al: Ethical, Social and economic issues in familial breast cancer: A compilation of views from the E.C. Biomed 11 Demonstration Project. Dis Markers 1999; 15: 125-131.
12. Kinmonth AL, Reinhard J, Bobrow M, Pauker S: The new genetics. Implications for clinical services in Britain and the United States. BMJ 1998; 316: 767-770.
13. Drummond MF, O'Brien B, Stoddart GL, Torrance G: Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1997.
14. National Institute for Health Clinical Excellence: Appraisal of new and existing technologies: Interim guidance for manufacturers and sponsors, 2004.
15. Aitken J, Bain C, Ward M, Siskind V, Maclennan R: How accurate is self-reported family history of colorectal cancer? Am J Epidemiol 1995; 141: 863-871.
16. Sijmons RH, Boonstra AE, Reefhuis J et al: Accuracy of family history of cancer: Clinical genetic implications. Eur J Hum Genet 2000; 8: 181-186.